| Health / Medical Topics |
Avasimibe
An orally bioavailable inhibitor of acyl-Coenzyme A:cholesterol acyltransferase (ACAT) that prevents cholesterol deposition in the arterial wall. Research was discontinued due to difficulties in assaying the effects of avasimibe on preventing plaque formation and due to its ability to increase the activity of Cytochrome P450 3A4, thus increasing the removal of other drugs from the body. (NCI Thesaurus)
YOU MAY ALSO LIKE
Necrotic changes in the bone tissue due to interruption of blood supply. Most often affecting the epiphysis of the long bones, the…
A condition in which there is a loss of blood flow to bone tissue, which causes the bone to die. It is…
A drug that helps control the amount of glucose (sugar) in the blood and is being studied in the prevention and treatment…
An orally available phosphodiesterase type 5 (PDE5) inhibitor with vasodilatory activity. Avanafil selectively inhibits PDE5, thus inhibiting the degradation of cyclic guanosine…
Specifies whether or not an entity is accessible for assessment or testing.
The quality of being obtainable or accessible and ready for use or service.
